ERBB2 and breast cancer: Based on our findings, circulating triglycerides are protective factors against the occurrence of overall breast cancer, HER2 (overexpressing type) breast cancer, and luminal A breast cancer, but they have no significant impact on the occurrence of the other molecular subtypes of breast cancer.